Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-15-001663
Filing Date
2015-01-29
Accepted
2015-01-29 20:47:08
Documents
1
Period of Report
2015-01-29

Document Format Files

Seq Description Document Type Size
1 rrd421763.html 3  
1 rrd421763.xml 3 3860
  Complete submission text file 0001181431-15-001663.txt   5229
Mailing Address
Business Address
SANDELL SCOTT D (Reporting) CIK: 0001237289 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36818 | Film No.: 15560596

Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)